Task: Answer the multiple-choice question.
Query: Which drug exhibits a 14.501\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) Cc1ccc(C(=O)N(CC(=O)NC2CCCC2)c2cccc(F)c2)s1
(b) CCOC(=O)C(C)NC(=O)CCc1nnc2ccc(N3CCC(C)CC3)nn12
Answer: b. CCOC(=O)C(C)NC(=O)CCc1nnc2ccc(N3CCC(C)CC3)nn12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)C(C)NC(=O)CCc1nnc2ccc(N3CCC(C)CC3)nn12
CCOC(=O)C(C)NC(=O)CCc1nnc2ccc(N3CCC(C)CC3)nn12
ethyl2-[3-[6-(4-methylpiperidin-1-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate